Healthgen Biotech focuses on plant molecular pharmaceutical technology base on rice endosperm cell specific expression platform (Oryzᴴⁱᴱˣᵖ). We are committed to supplying green, safe, accessible and sufficient biopharmaceutical products to people worldwide and improving global public health. Among our pipelines, the HY1001, Recombinant human albumin injection(Oryza Sativa), has obtained marketing approval in China.